Stroke Trial, Recruiting NCT07447804 Sponsor: Fenerbahce University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07447804
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 18 and 80 years old
  • People who have been diagnosed with hemiplegia (paralysis or weakness on one side of the body)
  • People who are in the subacute phase of their condition, meaning between 1 and 6 months after it first began
  • People who are able to tolerate an ultrasound scan of the diaphragm (the main breathing muscle) and breathing strength tests
  • People who score 24 or above on a standard memory and thinking assessment called the MMSE
  • People who are sufficiently alert and able to follow instructions and cooperate during the study

Who may not be able to join:

  • People who have existing lung conditions such as COPD, asthma, or interstitial lung disease
  • People who have paralysis of the diaphragm or a significant deformity of the chest wall
  • People who have an acute (sudden or active) heart or lung condition that prevents breathing function tests from being carried out
  • People with severe cognitive impairment (serious difficulties with thinking or memory) that could affect the accuracy of measurements
  • People who are unable to have an ultrasound assessment due to previous surgery on the stomach or abdomen

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sümeyye Akçay, Asst. Prof., Fenerbahçe University

Phone: +905424002553

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fenerbahce University
Registry
ClinicalTrials.gov
Start date
26 February 2026
Est. completion
26 July 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Mini-Mental State Examination (MMSE); Respiratory Muscle Strength (MIP); Respiratory Muscle Strength (MEP); Diaphragmatic Ultrasonography

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov